Secondaries announced 01.25.2017

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Entellus Medical, Inc.
Symbol: ENTL
Price: Last trade $19.39
Description: Re-offer range $17.00-$18.00
Trade Date: 1/26
Shares: 3.1 million
Underwriter(s)BofA Merrill Lynch, Piper Jaffray
Co Manager(s)William Blair & Co.
Rating=Subscription Needed

Company: Sinovac Biotech
Symbol: SVA
Price: Last trade $5.84
Description: Re-offer $5.55
Trade Date: 1/26
Shares: 1.25 million
Underwriter(s)Morgan Stanley
Rating=Subscription Needed

Company: Virtus Investment Partners, Inc.
Symbol: VRTS
Price: Last trade $125.65
Description: Convertible Preferred Stock=$100mm
Trade Date: 1/27
Shares: 800,000
Underwriter(s)Barclays, Morgan Stanley, J.P. Morgan, BofA Merrill Lynch
Rating=Subscription Needed